O'Shaughnessy Asset Management, LLC Arvinas, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$65.85 - $96.21 $75,003 - $109,583	-1,139 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$60.45 - $84.26 $29,801 - $41,540	-493 Reduced 30.21%	1,139 $88,000
Q4 2020 Feb 11, 2021	SELL	$20.19 - $84.93 $31,193 - $131,216	-1,545 Reduced 48.63%	1,632 $139,000
Q3 2020 Nov 12, 2020	SELL	$22.99 - $36.34 $12,483 - $19,732	-543 Reduced 14.6%	3,177 $75,000
Q2 2020 Aug 13, 2020	SELL	$29.88 - $56.74 $19,631 - $37,278	-657 Reduced 15.01%	3,720 $125,000
Q1 2020 May 13, 2020	BUY	$33.0 - $54.5 $144,441 - $238,546	4,377 New	4,377 $177,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.23B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.